These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16932267)

  • 41. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-density lipoprotein profile changes during the neonatal period.
    Fujita H; Okada T; Inami I; Makimoto M; Hosono S; Minato M; Takahashi S; Mugishima H; Yamamoto T
    J Perinatol; 2008 May; 28(5):335-40. PubMed ID: 18337737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
    Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
    Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study.
    Waters DD; LaRosa JC; Barter P; Fruchart JC; Gotto AM; Carter R; Breazna A; Kastelein JJ; Grundy SM
    J Am Coll Cardiol; 2006 Nov; 48(9):1793-9. PubMed ID: 17084252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HDL subspecies in young adult twins: heritability and impact of overweight.
    Pietiläinen KH; Söderlund S; Rissanen A; Nakanishi S; Jauhiainen M; Taskinen MR; Kaprio J
    Obesity (Silver Spring); 2009 Jun; 17(6):1208-14. PubMed ID: 19584879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. To help save the heart, is it time to retire cholesterol tests?
    Leslie M
    Science; 2017 Dec; 358(6368):1237-1238. PubMed ID: 29217551
    [No Abstract]   [Full Text] [Related]  

  • 50. In reply.
    Cole TG; Contois JH; Csako G; McConnell JP; Remaley AT; Devaraj S; Hoefner DM; Mallory T; Sethi AA; Warnick GR
    Clin Chem; 2013 Aug; 59(8):1277-8. PubMed ID: 24049794
    [No Abstract]   [Full Text] [Related]  

  • 51. Genetics and molecular biology.
    Semenkovich CF
    Curr Opin Lipidol; 1998 Dec; 9(6):603-4. PubMed ID: 10075479
    [No Abstract]   [Full Text] [Related]  

  • 52. The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease?
    Després JP
    CMAJ; 1993 Apr; 148(8):1339-40. PubMed ID: 8462056
    [No Abstract]   [Full Text] [Related]  

  • 53. Are LDL subclass measurements clinically relevant?
    Stein EA
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):120-1. PubMed ID: 16932267
    [No Abstract]   [Full Text] [Related]  

  • 54. Atherogenic lipoprotein subprofiling.
    Ellington AA; Kullo IJ
    Adv Clin Chem; 2008; 46():295-317. PubMed ID: 19004193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.
    Davidson MH
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1582-3. PubMed ID: 18716322
    [No Abstract]   [Full Text] [Related]  

  • 56. [Measurement of apolipoproteins is better than routinely measured traditional lipids].
    Kallner A; Estonius M
    Lakartidningen; 2006 Mar 8-14; 103(10):753-6, 758. PubMed ID: 16610202
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.